Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) EBT Margin (2021 - 2025)

Lucid Diagnostics' EBT Margin history spans 5 years, with the latest figure at 1084.4% for Q4 2025.

  • For Q4 2025, EBT Margin fell 12024.0% year-over-year to 1084.4%; the TTM value through Dec 2025 reached 1226.95%, down 17934.0%, while the annual FY2025 figure was 1234.26%, 18665.0% down from the prior year.
  • EBT Margin reached 1084.4% in Q4 2025 per LUCD's latest filing, down from 866.42% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 4192.52% in Q2 2021 to a low of 18880.26% in Q3 2022.
  • Average EBT Margin over 5 years is 3621.67%, with a median of 1471.06% recorded in 2023.
  • Peak YoY movement for EBT Margin: tumbled -1540176bps in 2022, then skyrocketed 1706570bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 3768.67% in 2021, then plummeted by -254bps to 13328.57% in 2022, then surged by 92bps to 1041.35% in 2023, then rose by 7bps to 964.16% in 2024, then decreased by -12bps to 1084.4% in 2025.
  • Per Business Quant, the three most recent readings for LUCD's EBT Margin are 1084.4% (Q4 2025), 866.42% (Q3 2025), and 369.92% (Q2 2025).